This page is a guide to SBIO, the ALPS Medical Breakthroughs ETF offered by ALPS.
Last Price
$20.65
+3.20%
How is SBIO Categorized as an ETF?
All ETFs
1,754 funds
Asset Class
985 ETFs
Category
273 ETFs
Sub-Category
9 ETFs
How Does SBIO Compare to Its Category Competitors?
The percentile shown for each metric indicates how SBIO compares to other ETFs in the Sector Stock category. Wondering how percentiles work? Short version: 99th percentile is good, 0th is bad.
Assets and Yield
Assets (Millions)
$103.85
46th Percentile
Dividend Yield
N/A
N/A
Returns
YTD Return
-28.08%
1st Percentile
5 Year Return
N/A
N/A
Portfolio
Number of Holdings
93
73rd Percentile
% Assets in Top 10
34.62%
71st Percentile
Expenses
Expense Ratio
0.50%
46th Percentile
Fund Turnover
25.00%
39th Percentile
SBIO vs. Other Sector Stock ETFs: All the Data You Could Possibly Want
The table below shows additional financial metrics for SBIO as well as all other ETFs in the Sector Stock category. To compare SBIO to its broader asset class peer group, visit the Stock page. To compare SBIO to its narrower sub-category peer group, visit the Biotech ETFs page.
Click on the tabs (Expenses, Returns, Yield, Holdings) to view additional data for SBIO and all ETFs in the Sector Stock category.
| Ticker | ETF | Assets ($M) | Inception Date | Issuer |
|---|---|---|---|---|
| Category Average | N/A | $821.16 | N/A | N/A |
| Ticker | ETF | Expense Ratio | Fund Turnover |
|---|---|---|---|
| Category Average | N/A | 0.62% | 33.14% |
| Ticker | ETF | YTD | 1-Month | 3-Month | 6-Month | 1-Year | 3-Year | 5-Year | 10-Year |
|---|---|---|---|---|---|---|---|---|---|
| Category Average | N/A | -7.91% | -7.58% | -11.49% | -15.36% | -13.96% | 1.53% | 2.85% | 5.10% |
| Ticker | ETF | 12 Month Yield | 30 Day SEC Yield | Dividend Frequency | Capital Gains Frequency |
|---|---|---|---|---|---|
| Category Average | N/A | 3.03% | 2.29% | N/A | N/A |
| Ticker | ETF | Number of Holdings | Number of Long Holdings | Number of Short Holdings | % Assets in Top 10 |
|---|---|---|---|---|---|
| Category Average | N/A | 84 | 84 | 2 | 47.79% |
SBIO Portfolio
| Asset Class | Weight |
|---|---|
| US Stock Weighting | 92.57% |
| Non US Stock Weighting | 6.80% |
| Other Weighting | 0.64% |
| Top Holdings | Weight |
|---|---|
| Seattle Genetics Inc | 5.19% |
| Neurocrine Biosciences Inc | 4.22% |
| Anacor Pharmaceuticals Inc | 3.82% |
| Akorn Inc | 3.42% |
| Catalent Inc | 3.37% |
| Horizon Pharma PLC | 3.21% |
| Impax Laboratories Inc | 3.04% |
| Intercept Pharmaceuticals Inc | 2.97% |
| The Medicines Co | 2.76% |
| Kite Pharma Inc | 2.61% |
Other SBIO Metrics
Management
- Issuer
- ALPS
- Inception Date
- 12/30/2014
- Management Style
- Passive
- Benchmark
- Poliwogg Medical Brekthrough TR USD
Dividend Data
- Dividend Frequency
- Quarterly
- Capital Gains Frequency
- N/A
- Annual Dividend
- N/A
Pricing Data
- Day Range
- $19.77 / $20.65
- Bid/Ask
- $20.58 / $20.65
- 52 Week Low/High
- $19.18 / $40.33
Other Information
- Leveraged Fund
- No
